Startups channel feed – Endpoints News

Startups channel feed

Alumis aims for this year’s third-largest biotech IPO as it readies for Phase 3

11 months ago

Tectonic enters public markets in one of few biotech reverse mergers this year

11 months ago

Gilead tested an antibody many times. A small biotech salvages it, with $40M and ‘conviction’ elsewhere

11 months ago

Roche strikes neuro-focused partnership with RNA exon editing startup, worth as much as $1.8B

11 months ago

As it deepens immunology bets, Sanofi inks small molecule pact with Belharra

11 months ago

Marea Therapeutics launches with $190M, seeing a 'fixable problem' in a neglected cardiometabolic target

11 months ago

Life sciences investor Decheng Capital targets $700M for fifth fund

11 months ago

Telehealth startup Done's execs arrested and charged for alleged Adderall scheme, DOJ says

11 months ago

Is $13B Devoted Health succeeding where other insurance upstarts have failed?

11 months ago

'Speed is everything': Versant-backed immunology startup raises $125M with plans for quick data

11 months ago

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

11 months ago

Foresite Capital closes $900M sixth fund, backing the likes of Xaira and IPO hopeful Alumis

11 months ago

Verily gets into the GLP-1 business with new program to manage cardiac and metabolic conditions

11 months ago

ARCH backs lab instrument company that wants to help demystify how cells talk to each other

11 months ago

Virtual physical therapy programs can be just as good as in-person care, report says

11 months ago

Australian life sciences VC Brandon Capital raises $180M for sixth fund

11 months ago

How FarmboxRx uses food deliveries to encourage patients to get preventive care

11 months ago

Rapport Therapeutics sets out for $122M Nasdaq debut as IPO backlog seeks fresh air

11 months ago

Joe Jimenez and Mark Fishman target $400M for third fund after leaving Novartis

11 months ago

CinRx raises $73M to create more biotechs, further support obesity drug development

12 months ago

Merck returns to lucrative eye disease market in up to $3B deal for EyeBio

12 months ago

Canadian biotech VC Amplitude raises $192M second fund

12 months ago

Gilead forms pact with Cartography to map new targets for cancer drugs

12 months ago

BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact

12 months ago

First page Previous page 14 15 161718 19 20 Next page Last page